The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Targeting SphK1 as a New Strategy against Cancer
Open accessAbstract
Sphingolipid metabolites have emerged as critical players in a number of fundamental biological processes. Among them, sphingosine-1-phosphate (S1P) promotes cell survival and proliferation, in contrast to ceramide and sphingosine, which induce cell growth arrest and apoptosis. These sphingolipids with opposing functions are interconvertible inside cells, suggesting that a finely tuned balance between them can determine cell fate. Sphingosine kinases (SphKs), which catalyze the phosphorylation of sphingosine to S1P, are critical regulators of this balance. Of the two identified SphKs, sphingosine kinase type 1 (SphK1) has been shown to regulate various processes important for cancer progression and will be the focus of this review, since much less is known of biological functions of SphK2, especially in cancer. SphK1 is overexpressed in various types of cancers and upregulation of SphK1 has been associated with tumor angiogenesis and resistance to radiation and chemotherapy. Many growth factors, through their tyrosine kinase receptors (RTKs), stimulate SphK1 leading to a rapid increase in S1P. This S1P in turn can activate S1P receptors and their downstream signaling. Conversely, activation of S1P receptors can induce transactivation of various RTKs. Thus, SphK1 may play important roles in S1P receptor RTK amplification loops. Here we review the role of SphK1 in tumorigenesis, hormonal therapy, chemotherapy resistance, and as a prognostic marker. We will also review studies on the effects of SphK inhibitors in cells in vitro and in animals in vivo and in some clinical trials and highlight the potential of SphK1 as a new target for cancer therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genetic Alterations during Colorectal-Tumor Development
Vogelstein, B., Fearon, E. R., Hamilton, S. R., Kern, S. E., Preisinger, A. C., Leppert, M., Smits, A. M. M., & Bos, J. L. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809013190901 · Cited by 6,728
Sphingosine-1-phosphate: an enigmatic signalling lipid
Spiegel, S., & Milstien, S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1103 · Cited by 2,075
Self-citationCetuximab for the Treatment of Colorectal Cancer
Jonker, D. J., O'Callaghan, C. J., Karapetis, C. S., Zalcberg, J. R., Tu, D., Au, H.-J., Berry, S. R., Krahn, M., Price, T., Simes, R. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071834 · Cited by 1,904
A Comparison of Letrozole and Tamoxifen in Postmenopausal Women with Early Breast Cancer
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052258 · Cited by 1,577
Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors
Daub, H., Ulrich Weiss, F., Wallasch, C., & Ullrich, A. (1996) · Nature · doi:10.1038/379557a0 · Cited by 1,476
Biologically active sphingolipids in cancer pathogenesis and treatment
Ogretmen, B., & Hannun, Y. A. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1411 · Cited by 1,213
Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C.-X., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S.-S., Lee, M.-J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10905 · Cited by 1,149
Self-citationLee, M.-J., Thangada, S., Claffey, K. P., Ancellin, N., Liu, C. H., Kluk, M., Volpi, M., Sha'afi, R. I., & Hla, T. (1999) · Cell · doi:10.1016/s0092-8674(00)81661-x · Cited by 1,013
Ma, X.-J., Wang, Z., Ryan, P. D., Isakoff, S. J., Barmettler, A., Fuller, A., Muir, B., Mohapatra, G., Salunga, R., Tuggle, J. T., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.05.015 · Cited by 954
Essential Role for Sphingosine Kinases in Neural and Vascular Development
Mizugishi, K., Yamashita, T., Olivera, A., Miller, G. F., Spiegel, S., & Proia, R. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.11113-11121.2005 · Cited by 742
Self-citation“Inside-Out” Signaling of Sphingosine-1-Phosphate: Therapeutic Targets
Takabe, K., Paugh, S. W., Milstien, S., & Spiegel, S. (2008) · Pharmacological Reviews · doi:10.1124/pr.107.07113 · Cited by 718
Self-citationSphingosine 1-phosphate and its receptors: an autocrine and paracrine network
Rosen, H., & Goetzl, E. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1650 · Cited by 694
Liu, H., Sugiura, M., Nava, V. E., Edsall, L. C., Kono, K., Poulton, S., Milstien, S., Kohama, T., & Spiegel, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002759200 · Cited by 667
Self-citationSphK1 and SphK2, Sphingosine Kinase Isoenzymes with Opposing Functions in Sphingolipid Metabolism
Maceyka, M., Sankala, H., Hait, N. C., Le Stunff, H., Liu, H., Toman, R., Collier, C., Zhang, M., Satin, L. S., Merrill, A. H., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502207200 · Cited by 636
Self-citationDiscovery and evaluation of inhibitors of human sphingosine kinase.
French, K. J., Schrecengost, R. S., Lee, B. D., Zhuang, Y., Smith, S. N., Eberly, J. L., Yun, J. K., & Smith, C. D. (2003) · PubMed · Cited by 599
Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation
Pitson, S. M. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg540 · Cited by 542
Novel Genes Associated with Malignant Melanoma but not Benign Melanocytic Lesions
Talantov, D., Mazumder, A., Yu, J. X., Briggs, T., Jiang, Y., Backus, J., Atkins, D., & Wang, Y. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0683 · Cited by 521
Visentin, B., Vekich, J. A., Sibbald, B. J., Cavalli, A. L., Moreno, K. M., Matteo, R. G., Garland, W. A., Lu, Y., Yu, S., Hall, H. S., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.02.023 · Cited by 463
Pyeon, D., Newton, M. A., Lambert, P. F., den Boon, J. A., Sengupta, S., Marsit, C. J., Woodworth, C. D., Connor, J. P., Haugen, T. H., Smith, E. M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3619 · Cited by 460
Gene Expression in the Urinary Bladder
Dyrskjøt, L., Kruhøffer, M., Thykjaer, T., Marcussen, N., Jensen, J. L., Møller, K., & Ørntoft, T. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3620 · Cited by 451
Mice Deficient in Sphingosine Kinase 1 Are Rendered Lymphopenic by FTY720
Allende, M. L., Sasaki, T., Kawai, H., Olivera, A., Mi, Y., van Echten-Deckert, G., Hajdu, R., Rosenbach, M., Keohane, C. A., Mandala, S., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406512200 · Cited by 447
Self-citationRole of the Sphingosine-1-Phosphate Receptor EDG-1 in PDGF-Induced Cell Motility
Hobson, J. P., Rosenfeldt, H. M., Barak, L. S., Olivera, A., Poulton, S., Caron, M. G., Milstien, S., & Spiegel, S. (2001) · Science · doi:10.1126/science.1057559 · Cited by 426
Self-citationSphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis
Igarashi, N., Okada, T., Hayashi, S., Fujita, T., Jahangeer, S., & Nakamura, S.-I. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306577200 · Cited by 415
Role of ABCC1 in export of sphingosine-1-phosphate from mast cells
Mitra, P., Oskeritzian, C. A., Payne, S. G., Beaven, M. A., Milstien, S., & Spiegel, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603734103 · Cited by 407
Self-citationGinos, M. A., Page, G. P., Michalowicz, B. S., Patel, K. J., Volker, S. E., Pambuccian, S. E., Ondrey, F. G., Adams, G. L., & Gaffney, P. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2144 · Cited by 407
Murata, N., Sato, K., Kon, J., Tomura, H., YANAGITA, M., Kuwabara, A., Ui, M., & Okajima, F. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3520809 · Cited by 407
An oncogenic role of sphingosine kinase
Xia, P., Gamble, J. R., Wang, L., Pitson, S. M., Moretti, P. A. B., Wattenberg, B. W., D'Andrea, R. J., & Vadas, M. A. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00834-4 · Cited by 394
Sphingosine Kinase Type 2 Is a Putative BH3-only Protein That Induces Apoptosis
Liu, H., Toman, R. E., Goparaju, S. K., Maceyka, M., Nava, V. E., Sankala, H., Payne, S. G., Bektas, M., Ishii, I., Chun, J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304455200 · Cited by 356
Self-citationLysophospholipids Are Potential Biomarkers of Ovarian Cancer
Sutphen, R., Xu, Y., Wilbanks, G. D., Fiorica, J., Grendys, E. C., LaPolla, J. P., Arango, H., Hoffman, M. S., Martino, M., Wakeley, K., et al. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.1185.13.7 · Cited by 338
Neviani, P., Santhanam, R., Oaks, J. J., Eiring, A. M., Notari, M., Blaser, B. W., Liu, S., Trotta, R., Muthusamy, N., Gambacorti-Passerini, C., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31095 · Cited by 335
Van Brocklyn, J. R., Jackson, C. A., Pearl, D. K., Kotur, M. S., Snyder, P. J., & Prior, T. W. (2005) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000175329.59092.2c · Cited by 330
Ruckhäberle, E., Rody, A., Engels, K., Gaetje, R., von Minckwitz, G., Schiffmann, S., Grösch, S., Geisslinger, G., Holtrich, U., Karn, T., et al. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9836-9 · Cited by 302
Autocrine and paracrine roles of sphingosine-1-phosphate
Alvarez, S. E., Milstien, S., & Spiegel, S. (2007) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2007.07.005 · Cited by 293
Self-citationKorkola, J. E., Houldsworth, J., Chadalavada, R. S. V., Olshen, A. B., Dobrzynski, D., Reuter, V. E., Bosl, G. J., & Chaganti, R. S. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2445 · Cited by 292
Safety of Treatment of Metastatic Breast Cancer With Trastuzumab Beyond Disease Progression
Tripathy, D., Slamon, D. J., Cobleigh, M., Arnold, A., Saleh, M., Mortimer, J. E., Murphy, M., & Stewart, S. J. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.557 · Cited by 280
Sphingosine Kinase: Biochemical and Cellular Regulation and Role in Disease
Taha, T. A., Hannun, Y. A., & Obeid, L. M. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.2.113 · Cited by 276
Pitson, S. M., Xia, P., Leclercq, T. M., Moretti, P. A. B., Zebol, J. R., Lynn, H. E., Wattenberg, B. W., & Vadas, M. A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040559 · Cited by 268
Schäfer, B., Gschwind, A., & Ullrich, A. (2004) · Oncogene · doi:10.1038/sj.onc.1207278 · Cited by 266
Antitumor Activity of Sphingosine Kinase Inhibitors
French, K. J., Upson, J. J., Keller, S. N., Zhuang, Y., Yun, J. K., & Smith, C. D. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.101345 · Cited by 242
Gschwind, A., Prenzel, N., & Ullrich, A. (2002) · PubMed · Cited by 242
Sukocheva, O., Wadham, C., Holmes, A., Albanese, N., Verrier, E., Feng, F., Bernal, A., Derian, C. K., Ullrich, A., Vadas, M. A., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200506033 · Cited by 228
Sphingosine Kinase Type 1 Promotes Estrogen-Dependent Tumorigenesis of Breast Cancer MCF-7 Cells
Nava, V (2002) · Experimental Cell Research · doi:10.1006/excr.2002.5658 · Cited by 226
Chae, S.-S., Paik, J.-H., Furneaux, H., & Hla, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422716 · Cited by 220
Purification and Characterization of Rat Kidney Sphingosine Kinase
Olivera, A., Kohama, T., Tu, Z., Milstien, S., & Spiegel, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12576 · Cited by 219
Self-citationFunctions of the Multifaceted Family of Sphingosine Kinases and Some Close Relatives
Spiegel, S., & Milstien, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r600028200 · Cited by 219
Self-citationOskouian, B., Sooriyakumaran, P., Borowsky, A. D., Crans, A., Dillard-Telm, L., Tam, Y. Y., Bandhuvula, P., & Saba, J. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600050103 · Cited by 218
Sphingosine kinase 1 is up‐regulated in colon carcinogenesis
Kawamori, T., Osta, W., Johnson, K. R., Pettus, B. J., Bielawski, J., Tanaka, T., Wargovich, M. J., Reddy, B. S., Hannun, Y. A., Obeid, L. M., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4331fje · Cited by 217
Maurer, B. J. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.23.1897 · Cited by 215
Ceramide Kinase Mediates Cytokine- and Calcium Ionophore-induced Arachidonic Acid Release
Pettus, B. J., Bielawska, A., Spiegel, S., Roddy, P., Hannun, Y. A., & Chalfant, C. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304816200 · Cited by 213
Self-citationIntracellular Role for Sphingosine Kinase 1 in Intestinal Adenoma Cell Proliferation
Kohno, M., Momoi, M., Oo, M. L., Paik, J.-H., Lee, Y.-M., Venkataraman, K., Ai, Y., Ristimaki, A. P., Fyrst, H., Sano, H., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02341-05 · Cited by 210
Hong, Y., Ho, K. S., Eu, K. W., & Cheah, P. Y. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1633 · Cited by 207
Sarkar, S., Maceyka, M., Hait, N. C., Paugh, S. W., Sankala, H., Milstien, S., & Spiegel, S. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.08.055 · Cited by 205
Self-citationSphingosine Kinase-1 as a Chemotherapy Sensor in Prostate Adenocarcinoma Cell and Mouse Models
Pchejetski, D., Golzio, M., Bonhoure, E., Calvet, C., Doumerc, N., Garcia, V., Mazerolles, C., Rischmann, P., Teissié, J., Malavaud, B., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2702 · Cited by 205
Igarashi, J., Erwin, P. A., Dantas, A. P. V., Chen, H., & Michel, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1934494100 · Cited by 192
Andersson, A., Ritz, C., Lindgren, D., Edén, P., Lassen, C., Heldrup, J., Olofsson, T., Råde, J., Fontes, M., Porwit-MacDonald, A., et al. (2007) · Leukemia · doi:10.1038/sj.leu.2404688 · Cited by 189
Tanimoto, T., Jin, Z.-G., & Berk, B. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204764200 · Cited by 188
Suppression of Ulcerative Colitis in Mice by Orally Available Inhibitors of Sphingosine Kinase
Maines, L. W., Fitzpatrick, L. R., French, K. J., Zhuang, Y., Xia, Z., Keller, S. N., Upson, J. J., & Smith, C. D. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-0133-6 · Cited by 184
Critical role of ABCA1 transporter in sphingosine 1-phosphate release from astrocytes
Sato, K., Malchinkhuu, E., Horiuchi, Y., Mogi, C., Tomura, H., Tosaka, M., Yoshimoto, Y., Kuwabara, A., & Okajima, F. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04958.x · Cited by 183
Immunohistochemical Distribution of Sphingosine Kinase 1 in Normal and Tumor Lung Tissue
Johnson, K. R., Johnson, K. Y., Crellin, H. G., Ogretmen, B., Boylan, A. M., Harley, R. A., & Obeid, L. M. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.4a6606.2005 · Cited by 183
Limaye, V., Li, X., Hahn, C., Xia, P., Berndt, M. C., Vadas, M. A., & Gamble, J. R. (2005) · Blood · doi:10.1182/blood-2004-02-0452 · Cited by 177
Bonhoure, E., Pchejetski, D., Aouali, N., Morjani, H., Levade, T., Kohama, T., & Cuvillier, O. (2006) · Leukemia · doi:10.1038/sj.leu.2404023 · Cited by 170
Itoh, M., Kitano, T., Watanabe, M., Kondo, T., Yabu, T., Taguchi, Y., Iwai, K., Tashima, M., Uchiyama, T., & Okazaki, T. (2003) · PubMed · Cited by 166
Sankala, H. M., Hait, N. C., Paugh, S. W., Shida, D., Lépine, S., Elmore, L. W., Dent, P., Milstien, S., & Spiegel, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2090 · Cited by 161
Self-citationSphingosine 1-phosphate is released from the cytosol of rat platelets in a carrier-mediated manner
Kobayashi, N., Nishi, T., Hirata, T., Kihara, A., Sano, T., Igarashi, Y., & Yamaguchi, A. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500468-jlr200 · Cited by 159
Role of Sphingosine Kinase 2 in Cell Migration toward Epidermal Growth Factor
Hait, N. C., Sarkar, S., Le Stunff, H., Mikami, A., Maceyka, M., Milstien, S., & Spiegel, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502922200 · Cited by 158
Self-citationA novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells
Matsuoka, Y., Nagahara, Y., Ikekita, M., & Shinomiya, T. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705182 · Cited by 152
Liu, F., Verin, A. D., Wang, P., Day, R. M., Wersto, R. P., Chrest, F. J., English, D. K., & Garcia, J. G. N. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.6.4323 · Cited by 146
Taha, T. A., Kitatani, K., El‐Alwani, M., Bielawski, J., Hannun, Y. A., & Obeid, L. M. (2005) · The FASEB Journal · doi:10.1096/fj.05-4412fje · Cited by 145
The Mechanism of Membrane Targeting of Human Sphingosine Kinase 1
Stahelin, R. V., Hwang, J.-H., Kim, J.-H., Park, Z., Johnson, K. R., Obeid, L. M., & Cho, W. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507574200 · Cited by 143
Bektas, M., Jolly, P. S., Müller, C., Eberle, J., Spiegel, S., & Geilen, C. C. (2005) · Oncogene · doi:10.1038/sj.onc.1208019 · Cited by 140
Self-citationBillich, A., Bornancin, F., Mechtcheriakova, D., Natt, F., Huesken, D., & Baumruker, T. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2004.12.005 · Cited by 139
Nindl, I., Dang, C., Forschner, T., Kuban, R. ‐., Meyer, T., Sterry, W., & Stockfleth, E. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-30 · Cited by 136
Akao, Y., Banno, Y., Nakagawa, Y., Hasegawa, N., Kim, T., Murate, T., Igarashi, Y., & Nozawa, Y. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.070 · Cited by 134
Goparaju, S. K., Jolly, P. S., Watterson, K. R., Bektas, M., Alvarez, S. E., Sarkar, S., Mel, L., Ishii, I., Chun, J. J. M., Milstien, S., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.10.4237-4249.2005 · Cited by 134
Self-citationDown-regulation of Sphingosine Kinase-1 by DNA Damage
Taha, T. A., Osta, W. A., Kozhaya, L., Bielawski, J., Johnson, K. R., Gillanders, W. E., Dbaibo, G. S., Hannun, Y. A., & Obeid, L. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401259200 · Cited by 131
Manggau, M. A., Kim, D.-S., Ruwisch, L., Vogler, R., Schäfer-Korting, M., Kleuser, B., & Körting, H. C. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01496.x · Cited by 130
Ceramide levels are inversely associated with malignant progression of human glial tumors
Riboni, L., Campanella, R., Bassi, R., Villani, R. M., Gaini, S. M., Boneschi, F. M., Viani, P., & Tettamanti, G. (2002) · Glia · doi:10.1002/glia.10087 · Cited by 129
Wong, Y. F., Selvanayagam, Z., Wei, N., Porter, J. F., Vittal, R., Hu, R., Lin, Y., Liao, J. J. Z., Shih, J. W., Cheung, T. H., et al. (2003) · PubMed · Cited by 126
Chan, M. M., Lu, X. L., Merchant, F. M., Iglehart, J. D., & Miron, P. L. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi100 · Cited by 124
Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression
Scolan, E. L., Pchejetski, D., Banno, Y., Denis, N., Mayeux, P., Vainchenker, W., Levade, T., & Moreau-Gachelin, F. (2005) · Blood · doi:10.1182/blood-2004-12-4832 · Cited by 119
Gene Expression Profiles Associated with Treatment Response in Oligodendrogliomas
French, P. J., Swagemakers, S. M. A., Nagel, J. H. A., Kouwenhoven, M. C. M., Brouwer, E., van der Spek, P. J., Luider, T. M., Kros, J. M., van den Bent, M. J., & Smitt, P. A. E. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1886 · Cited by 116
Döll, F., Pfeilschifter, J. M., & Huwiler, A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.12.001 · Cited by 106
Updates on functions of ceramide in chemotherapy-induced cell death and in multidrug resistance
Öğretmen, B., & Hannun, Y. A. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0225 · Cited by 106
Endo, A., Nagashima, K.-I., Kurose, H., Mochizuki, S., Matsuda, M., & Mochizuki, N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111794200 · Cited by 104
Sachs, C. W., Safa, A. R., Harrison, S. D., & Fine, R. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.44.26639 · Cited by 99
Paugh, B. S., Paugh, S. W., Bryan, L., Kapitonov, D., Wilczynska, K. M., Gopalan, S. M., Rokita, H., Milstien, S., Spiegel, S., & Kordula, T. (2007) · The FASEB Journal · doi:10.1096/fj.07-8276com · Cited by 88
Self-citationKrump‐Konvalinkova, V., Yasuda, S., Rubic, T., Makarova, N., Mages, J., Erl, W., Vosseler, C. A., Kirkpatrick, C. J., Tigyi, G., & Siess, W. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000154360.36106.d9 · Cited by 87
Effects of LPA and S1P on the Nervous System and Implications for Their Involvement in Disease
Herr, D. R., & Chun, J. J. M. (2006) · Current Drug Targets · doi:10.2174/138945007779315669 · Cited by 86
Döll, F., Pfeilschifter, J. M., & Huwiler, A. (2007) · Endocrine Related Cancer · doi:10.1677/erc-06-0050 · Cited by 77
S1P 3 ‐mediated Akt activation and crosstalk with platelet‐derived growth factor receptor (PDGFR)
Baudhuin, L. M., Jiang, Y., Zaslavsky, A., Ishii, I., Chun, J. J. M., & Xu, Y. (2003) · The FASEB Journal · doi:10.1096/fj.03-0302fje · Cited by 76
Gamble, J. R., Xia, P., Hahn, C. N., Drew, J., Drogemuller, C., Brown, D., & Vadas, M. A. (2005) · International Journal of Cancer · doi:10.1002/ijc.21682 · Cited by 72
Cellular signalling by sphingosine kinase and sphingosine 1‐phosphate
Leclercq, T. M., & Pitson, S. M. (2006) · IUBMB Life · doi:10.1080/15216540600871126 · Cited by 64
Annabi, B., Thibeault, S., Lee, Y., Bousquet-Gagnon, N., Eliopoulos, N., Barrette, S., Galipeau, J., & Béliveau, R. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(03)00090-0 · Cited by 62
Khan, W. A., Dobrowsky, R. T., Touny, S. E., & Hannun, Y. A. (1990) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(90)90728-6 · Cited by 57
Samy, E. T., Meyer, C. A., Caplazi, P., Langrish, C. L., Lora, J. M., Bluethmann, H., & Peng, S. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.5644 · Cited by 49
Modulation of P‐glycoprotein function by sphingosine kinase‐1 in brain endothelial cells
Pilorget, A., Demeule, M., Barakat, S., Marvaldi, J. L., Luis, J., & Béliveau, R. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04295.x · Cited by 49
Lichtner, R. B. (2003) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2003.09.006 · Cited by 47
Jung‐Klawitter, S., Hofmann, L. P., Pfeilschifter, J. M., & Huwiler, A. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706983 · Cited by 39
Cited by
An update on sphingosine-1-phosphate and other sphingolipid mediators
Fyrst, H., & Saba, J. D. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.392 · Cited by 344
Nagahashi, M., Ramachandran, S., Kim, E. Y., Allegood, J. C., Rashid, O. M., Yamada, A., Zhao, R., Milstien, S., Zhou, H., Spiegel, S., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2167 · Cited by 315
Self-citationRegulation of sphingosine kinase and sphingolipid signaling
Pitson, S. M. (2011) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2010.08.001 · Cited by 307
Cancer-associated lysosomal changes: friends or foes?
Kallunki, T., Olsen, O. D., & Jäättelä, M. (2013) · Oncogene · doi:10.1038/onc.2012.292 · Cited by 298
Schnute, M. E., McReynolds, M. D., Kasten, T., Yates, M., Jerome, G., Rains, J. W., Hall, T., Chrencik, J., Kraus, M., Cronin, C. N., et al. (2012) · Biochemical Journal · doi:10.1042/bj20111929 · Cited by 280
Metadata
- Authors
- Shida, D., Takabe, K., Kapitonov, D., Milstien, S., & Spiegel, S.
- Venue
- Current Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2008-08-01
- Volume
- 9
- Issue
- 8
- Pages
- 662-673
- ISSN
- 1389-4501 (ISSN-L)
- OpenAlex
- W2147245292
- Cited by
- 307
- References
- 98
- FWCI
- 6.20
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.